Conduit Pharmaceuticals Inc. (CDT) — Financial Flexibility Index
Conduit Pharmaceuticals Inc. (CDT) has a Financial Flexibility Index of 0.01x as of March 2026. Free cash flow of $25.73 Million (operating CF $-18.67 Million minus capex $44.39 Million) represents 0% of total liabilities ($2.18 Billion). Check Conduit Pharmaceuticals Inc. liquidity resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Conduit Pharmaceuticals Inc. Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Conduit Pharmaceuticals Inc. across 5 annual periods. See how liquid is Conduit Pharmaceuticals Inc.'s working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Conduit Pharmaceuticals Inc. (2021–2025)
Year-by-year free cash flow to debt coverage for Conduit Pharmaceuticals Inc.. For the full company profile including market capitalisation, see Conduit Pharmaceuticals Inc. (CDT) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.01x | $-13.15 Million | $-15.55 Million | $2.28 Billion | ▲ +99.3% |
| 2024 | -0.88x | $-9.63 Million | $-9.68 Million | $10.99 Million | ▲ +12.8% |
| 2023 | -1.01x | $-7.72 Million | $-7.72 Million | $7.68 Million | ▼ -348.0% |
| 2022 | -0.22x | $-2.27 Million | $-2.27 Million | $10.09 Million | ▲ +98.0% |
| 2021 | -11.17x | $-2.15 Million | $-2.15 Million | $192.51K | — |